Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/31/14 → 12/31/16 |
Prism 301-A Phase 3, Open-Label, Randomized, Multi-Center Study to Assess the Safety and Tolerability of an Induction, Titration, and Maintenance Dose Regimen of BMN 165 Self Administered by Adults with Phenylketonuria Not Previously Treated with BMN 165
- Amato, Ralph (PI)